Omeros | OMER - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Adma Biologics USD 2.1M 474K 2026-03
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Cytokinetics USD 34.83M 1.5M 2026-06
Gilead Sciences USD 247M 7M 2026-06
Heron Therapeutics USD 600K 100K 2024-12
Immunic 197K 222K 2025-12
Insmed USD 18.84M 1.24M 2026-06
Knight Therapeutics CAD 3.92M 1.56M 2025-12
MacroGenics USD 4.89M 1.55M 2026-03
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.62M 77K 2026-06
Pfizer USD 667M 4M 2026-06
Rockwell Medical USD 232K 199K 2024-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
United Therapeutics USD 2.9M 200K 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12